HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.

Abstract
Aerobic glycolysis and mitochondrial dysfunction are common features of aggressive cancer growth. We observed promoter methylation and loss of expression in neurofilament heavy polypeptide (NEFH) in a significant proportion of primary esophageal squamous cell carcinoma (ESCC) samples that were of a high tumor grade and advanced stage. RNA interference-mediated knockdown of NEFH accelerated ESCC cell growth in culture and increased tumorigenicity in vivo, whereas forced expression of NEFH significantly inhibited cell growth and colony formation. Loss of NEFH caused up-regulation of pyruvate kinase-M2 type and down-regulation of pyruvate dehydrogenase, via activation of the Akt/beta-catenin pathway, resulting in enhanced aerobic glycolysis and mitochondrial dysfunction. The acceleration of glycolysis and mitochondrial dysfunction in NEFH-knockdown cells was suppressed in the absence of beta-catenin expression, and was decreased by the treatment of 2-Deoxyglucose, a glycolytic inhibitor, or API-2, an Akt inhibitor. Loss of NEFH activates the Akt/beta-catenin pathway and increases glycolysis and mitochondrial dysfunction. Cancer cells with methylated NEFH can be targeted for destruction with specific inhibitors of deregulated downstream pathways.
AuthorsMyoung Sook Kim, Xiaofei Chang, Cynthia LeBron, Jatin K Nagpal, Juna Lee, Yiping Huang, Keishi Yamashita, Barry Trink, Edward A Ratovitski, David Sidransky
JournalPloS one (PLoS One) Vol. 5 Issue 2 Pg. e9003 (Feb 03 2010) ISSN: 1932-6203 [Electronic] United States
PMID20140245 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • API 2
  • Neurofilament Proteins
  • beta Catenin
  • neurofilament protein H
  • Deoxyglucose
  • Proto-Oncogene Proteins c-akt
  • Chlorpropamide
Topics
  • Animals
  • Apoptosis (genetics, physiology)
  • Blotting, Western
  • Carcinoma, Squamous Cell (genetics, metabolism, pathology)
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation
  • Chlorpropamide (analogs & derivatives, pharmacology)
  • DNA Methylation
  • Deoxyglucose (pharmacology)
  • Esophageal Neoplasms (genetics, metabolism, pathology)
  • Flow Cytometry
  • Gene Expression
  • Glycolysis (drug effects)
  • Humans
  • Mice
  • Mice, Nude
  • Neurofilament Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, metabolism)
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (drug effects, genetics, physiology)
  • Transplantation, Heterologous
  • Tumor Burden
  • beta Catenin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: